Illumina ( Illumina)

Primary tabs

Illumina's picture

Management

Contact Address

About Illumina

At Illumina, we apply innovative technologies for studying genetic variation and function, making studies possible that were not even imaginable just a few years ago. These revolutionary tools for DNA, RNA, and protein analysis are enabling rapid advances in disease research, drug development, and the development of molecular tests in the clinic.

Illumina press release, blog etc

Tue, 01/13/2026 - 14:53 Illumina introduces Billion Cell Atlas to accelerate AI and drug discovery
Thu, 01/08/2026 - 19:51 Illumina Appoints Dr. Eric Green as Chief Medical Officer
Tue, 01/06/2026 - 13:52 Illumina launches powerful software for connected, intuitive, and scalable multiomic analysis
Thu, 12/11/2025 - 16:46 Illumina and MyOme strike collaboration deal including strategic investment to support MyOmes clinical trial that could save US healthcare $200 billion annually
Wed, 10/15/2025 - 14:58 Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot
Wed, 10/15/2025 - 14:58 Illumina fuels multiomic discovery with launch of 5-base solution, unlocking simultaneous genomic and epigenomic insights
Tue, 09/23/2025 - 14:17 Illumina advances personalized cancer care with new pharma development partnerships
Thu, 09/18/2025 - 15:27 Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicine
Sat, 06/14/2025 - 13:20 lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics
Thu, 05/29/2025 - 15:20 Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
Wed, 05/28/2025 - 16:52 Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies
Tue, 05/27/2025 - 15:59 Illumina Comprehensive Genomic Profiling Test for Cancer Receives Regulatory Approval in Japan
Wed, 05/14/2025 - 04:05 Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications
Fri, 05/02/2025 - 03:48 Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development
Tue, 04/15/2025 - 11:05 Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation
Tue, 03/25/2025 - 14:00 Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors
Thu, 03/06/2025 - 15:53 Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year
Fri, 02/21/2025 - 14:06 Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions